Gal Shafirstein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Gal Shafirstein has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Chun‐Yang Fan
2 shared publications- Arjun Saradna
Pulmonary and Critical Care, University at Buffalo, Buffalo, NY, United States
1 shared publication - Barbara Bojko
Department of Pharmacodynamics and Molecular Pharmacology, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-089 Bydgoszcz, Poland
1 shared publication Christina Mimikos
Department of Head and Neck Surgery/Plastic and Reconstructive Surgery Roswell Park Cancer Institute Buffalo NY United States
1 shared publication- Daping Chen
School of Mechanic Engineering, Northeast Electric Power University, Jilin, China
1 shared publication - David A. Bellnier
Roswell Park Cancer Institute (USA)
1 shared publication
Latest Publications
- Open Access
- 22 July 2025
- Published by Wiley in Advanced Science
- Vol. 13 (1) , e00396
Minimally Invasive Chemical Biopsy Needle with Self‐Wettable Extraction Phase For In Vivo Tissue Sampling During Medical Procedures
Chemical biopsy by solid‐phase microextraction (SPME) with sorbent‐coated fibers offers monitoring of biological processes in a significantly less invasive manner compared to conventional tissue biopsy. The developed device features a self‐protective design by using an acupuncture needle coated with biocompatible material only in a recessed section. The coating comprises micron‐sized naturally wettable sorbent particles embedded in a durable, biocompatible binder, ensuring broad analyte extraction coverage without the need for solvent activation. This design allows professionals in biochemical research and medical staff to use the device for in vivo monitoring of tissue concentrations of endogenous and/or exogenous substances without introducing activation solvent to the investigated system. The device is successfully used to sample anti‐cancer drugs in both animal models and human patients undergoing in vivo lung perfusion (IVLP) surgery, and then determine the drug concentration level by LC/MS. Finally, a proof‐of‐concept experiment using a microfluidic open interface (MOI) to directly desorb and introduce the extract analytes from the coating to MS detection is proposed for potential on‐site real‐time drug monitoring during the surgery.
- 22 July 2025
- Published by Wiley in Advanced Science
- Vol. 13 (1) , e00396
Open AccessMinimally Invasive Chemical Biopsy Needle with Self‐Wettable Extraction Phase For In Vivo Tissue Sampling During Medical Procedures
Chemical biopsy by solid‐phase microextraction (SPME) with sorbent‐coated fibers offers monitoring of biological processes in a significantly less invasive manner compared to conventional tissue biopsy. The developed device features a self‐protective design by using an acupuncture needle coated with biocompatible material only in a recessed section. The coating comprises micron‐sized naturally wettable sorbent particles embedded in a durable, biocompatible binder, ensuring broad analyte extraction coverage without the need for solvent activation. This design allows professionals in biochemical research and medical staff to use the device for in vivo monitoring of tissue concentrations of endogenous and/or exogenous substances without introducing activation solvent to the investigated system. The device is successfully used to sample anti‐cancer drugs in both animal models and human patients undergoing in vivo lung perfusion (IVLP) surgery, and then determine the drug concentration level by LC/MS. Finally, a proof‐of‐concept experiment using a microfluidic open interface (MOI) to directly desorb and introduce the extract analytes from the coating to MS detection is proposed for potential on‐site real‐time drug monitoring during the surgery.
- Open Access
- 1 August 2017
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 9 (8) , 2613-2618
Endobronchial ultrasound—guidance for interstitial photodynamic therapy of locally advanced lung cancer—a new interventional concept
Recent advances in interventional pulmonology led to a significant expansion of the diagnostic and therapeutic role of endobronchial ultrasound. In this paper, we describe a new concept for using endobronchial ultrasound to guide interstitial photodynamic therapy (PDT). For this purpose, we conducted in vitro and in vivo experiments using a phantom and animal models, respectively. A new 0.5 mm optical fiber, with cylindrical diffuser end, was used to deliver the therapeutic light through the 21-gauge endobronchial ultrasound needle. The animal experiments were performed under real-time ultrasonography guidance in mice and rabbits’ tumor models. Safe and effective fiber placements and tumor illumination was accomplished. In addition, computer simulation of light propagation suggests that locally advanced lung cancer tumor can be illuminated. This study demonstrates the potential feasibility of this new therapeutic modality approach, justifying further investigation in the treatment of locally advanced lung cancers.
- 1 August 2017
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 9 (8) , 2613-2618
Open AccessEndobronchial ultrasound—guidance for interstitial photodynamic therapy of locally advanced lung cancer—a new interventional concept
Recent advances in interventional pulmonology led to a significant expansion of the diagnostic and therapeutic role of endobronchial ultrasound. In this paper, we describe a new concept for using endobronchial ultrasound to guide interstitial photodynamic therapy (PDT). For this purpose, we conducted in vitro and in vivo experiments using a phantom and animal models, respectively. A new 0.5 mm optical fiber, with cylindrical diffuser end, was used to deliver the therapeutic light through the 21-gauge endobronchial ultrasound needle. The animal experiments were performed under real-time ultrasonography guidance in mice and rabbits’ tumor models. Safe and effective fiber placements and tumor illumination was accomplished. In addition, computer simulation of light propagation suggests that locally advanced lung cancer tumor can be illuminated. This study demonstrates the potential feasibility of this new therapeutic modality approach, justifying further investigation in the treatment of locally advanced lung cancers.
- Open Access
- 1 June 2016
- Published by Wiley in World Journal of Otorhinolaryngology - Head and Neck Surgery
- Vol. 2 (2) , 126-129
Current state and future of photodynamic therapy for the treatment of head and neck squamous cell carcinoma
Photodynamic therapy has shown promise in the treatment of early head and neck squamous cell carcinoma (SCC). In photodynamic therapy (PDT), a light sensitive drug (photosensitizer) and visible light cause cancer cell death by the creation of singlet oxygen and free radicals, inciting an immune response, and vascular collapse. In this paper, we review several studies that demonstrate the effectiveness of PDT in the treatment of early stage SCC of the head and neck, with some showing a similar response rate to surgery. Two cases are presented to illustrate the effectiveness of PDT. Then, new advances are discussed including the discovery of STAT3 crosslinking as a potential biomarker for PDT response and interstitial PDT for locally advanced cancers.
- 1 June 2016
- Published by Wiley in World Journal of Otorhinolaryngology - Head and Neck Surgery
- Vol. 2 (2) , 126-129
Open AccessCurrent state and future of photodynamic therapy for the treatment of head and neck squamous cell carcinoma
Photodynamic therapy has shown promise in the treatment of early head and neck squamous cell carcinoma (SCC). In photodynamic therapy (PDT), a light sensitive drug (photosensitizer) and visible light cause cancer cell death by the creation of singlet oxygen and free radicals, inciting an immune response, and vascular collapse. In this paper, we review several studies that demonstrate the effectiveness of PDT in the treatment of early stage SCC of the head and neck, with some showing a similar response rate to surgery. Two cases are presented to illustrate the effectiveness of PDT. Then, new advances are discussed including the discovery of STAT3 crosslinking as a potential biomarker for PDT response and interstitial PDT for locally advanced cancers.
- 2 June 2010
- Published by Wiley in Medical Physics
- Vol. 37 (6Part8) , 3432
WE-D-201C-04: SonoKnife - Feasibility of Line-Focused Ultrasound for Thermal Ablation
- 2 June 2010
- Published by Wiley in Medical Physics
- Vol. 37 (6Part8) , 3432
WE-D-201C-04: SonoKnife - Feasibility of Line-Focused Ultrasound for Thermal Ablation
- 1 August 2008
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 139 (S2)
Natural History of Arteriovenous Malformations
Objective: 1) To demonstrate the natural history of arteriovenous malformation (AVMs) when left untreated or inadequately managed. 2) To demonstrate the need for major treatment to patients, families, healthcare providers, and insurance companies.Methods: Records from 10 of 50 representative patients treated at University of Arkansas for Medical Sciences (UAMS) for advanced AVMs were reviewed for age at presentation, gender, presenting symptoms, previous treatment, disease course, and post‐presentation management. Patients were asked if quality of life had improved after treatment at UAMS Facial photos from childhood were obtained and compared with photos taken at time of presentation.Results: 10 patients (7 male, 3 female, range 21–46 years) received treatment. All patients presented with bleeding, pain and/or facial destruction. 6 of 10 patients received previous embolization. No patients had undergone previous surgical resection. All were informed by a previous physician that the disease was incurable or treatment options had been exhausted. All patients experienced subsequent worsening of symptoMS All patients were treated at UAMS with preoperative embolization followed by surgical resection and required multiple surgeries to remove persistent AVM. All patients indicated quality of life improved after embolization/surgical resection. Comparison of photos revealed progression of disease in all cases marked by facial destruction and deformity.Conclusions: AVMs display a progressive and destructive nature when left untreated or inadequately managed. Natural history can be used to demonstrate to patients, families, and healthcare providers the seriousness of disease and convince insurance companies that radical treatment is typically necessary to obtain control or cure.
- 1 August 2008
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 139 (S2)
Natural History of Arteriovenous Malformations
Objective: 1) To demonstrate the natural history of arteriovenous malformation (AVMs) when left untreated or inadequately managed. 2) To demonstrate the need for major treatment to patients, families, healthcare providers, and insurance companies.Methods: Records from 10 of 50 representative patients treated at University of Arkansas for Medical Sciences (UAMS) for advanced AVMs were reviewed for age at presentation, gender, presenting symptoms, previous treatment, disease course, and post‐presentation management. Patients were asked if quality of life had improved after treatment at UAMS Facial photos from childhood were obtained and compared with photos taken at time of presentation.Results: 10 patients (7 male, 3 female, range 21–46 years) received treatment. All patients presented with bleeding, pain and/or facial destruction. 6 of 10 patients received previous embolization. No patients had undergone previous surgical resection. All were informed by a previous physician that the disease was incurable or treatment options had been exhausted. All patients experienced subsequent worsening of symptoMS All patients were treated at UAMS with preoperative embolization followed by surgical resection and required multiple surgeries to remove persistent AVM. All patients indicated quality of life improved after embolization/surgical resection. Comparison of photos revealed progression of disease in all cases marked by facial destruction and deformity.Conclusions: AVMs display a progressive and destructive nature when left untreated or inadequately managed. Natural history can be used to demonstrate to patients, families, and healthcare providers the seriousness of disease and convince insurance companies that radical treatment is typically necessary to obtain control or cure.
- 1 August 2006
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 135 (S2)
R195: Vascular Flow and Histology in Laser Treatment
- 1 August 2006
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 135 (S2)
R195: Vascular Flow and Histology in Laser Treatment